AVI BioPharma Inc. (AVII) Stock Quote

Detailed Quote for AVI BioPharma Inc. (AVII) 
$ 2.15 0.00 (0.00%) Volume: 119.62 k 10:42 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
2.15
Change $
Change %
Tick
  
Bid
2.15
Bid Size
2600
Ask
2.16
Ask Size
7800
Open
2.16
High
2.18
Low
2.15
Prev Close
2.15
Last Trade
10:42
Volume
119.62 k
52 Wk Hi
2.24
52 Wk Low
1.11
Market Cap
240.71 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
111,959,610
EPS (TTM)
-0.18
PE Ratio
N/A
Exchange
NSD
News and Media for AVI BioPharma Inc.  (AVII) 
Sector News | Topic News
News for AVII
Tue, Aug 24, 2010
8:00 AM AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100 - Marketwire
Mon, Aug 23, 2010
8:00 AM Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses - Marketwire
Mon, Aug 09, 2010
4:00 PM AVI BioPharma Announces Second Quarter 2010 Financial Results - Marketwire
Mon, Aug 02, 2010
11:00 AM AVI BioPharma Announces Second Quarter 2010 Financial Results and Corporate Update Conference Call - Marketwire
Thu, Jul 29, 2010
12:15 PM AVI BioPharma to Present at BMO Capital Markets Focus on Healthcare Conference - Marketwire
Tue, Jul 20, 2010
5:39 PM AVI BioPharma Awarded up to $291 Million U.S. Government Contract for Advanced Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses - Marketwire
Mon, Jul 19, 2010
6:50 AM AVI BioPharma Inc. is Today's Focus Stock on MicroStockProfit.com - Globe Newswire
Fri, Jul 16, 2010
1:00 PM AVI BioPharma Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at International Congress on Neuromuscular Diseases ; ; - Marketwire
7:45 AM AVI BioPharma Discloses New Contract With U.S. Government for Potential Funding of up to $291 Million to Advance Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses - Marketwire
Wed, Jul 07, 2010
8:00 AM AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy - Marketwire
Thu, Jun 10, 2010
2:00 PM AVI BioPharma to Present at ThinkEquity's Mid Year Check-Up on Healthcare Conference - Marketwire
Mon, Jun 07, 2010
9:45 AM AVI BioPharma Discloses New Contract With U.S. Government for up to $18 Million to Advance Development of AVI-7100 as H1N1 Flu Therapeutic - Marketwire
Thu, Jun 03, 2010
9:47 AM AVI BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference - Marketwire
Wed, Jun 02, 2010
7:01 AM AVI-4658 Demonstrates First Ever Reported Generation of Greater Than 50% Dystrophin-Positive Muscle Fibers in a Patient Following Systemic Administration in Duchenne Muscular Dystrophy; All Patients in Two Highest Dose Cohorts Generated New Dystrophin-Positive Fibers ; - Marketwire
Tue, May 11, 2010
8:30 AM AVI BioPharma to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference - Marketwire
Mon, May 10, 2010
4:01 PM AVI BioPharma Announces First Quarter 2010 Financial Results - Marketwire
Fri, May 07, 2010
8:00 AM AVI BioPharma and Collaborators Publish Data From Preclinical Studies Demonstrating the Antimicrobial Efficacy of PMO Oligomers Against Burkholderia Cepacia Complex in The Journal of Infectious Diseases - Marketwire
Mon, May 03, 2010
8:10 AM AVI BioPharma Announces First Quarter 2010 Financial Results and Corporate Update Conference Call - Marketwire
Wed, Apr 28, 2010
8:00 AM AVI BioPharma Secures Increased Funding of Approximately $4.0 Million Under Its Contract With the U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu - Marketwire
Wed, Apr 21, 2010
8:15 AM AVI BioPharma Appoints David Boyle Interim President and CEO - Marketwire
More News for AVII >>

Tags for AVI BioPharma Inc.

Research stocks or mutual funds related to AVI BioPharma Inc. by keywords or tags. Find companies that have a similar focus to AVII. The keywords below have been associated to AVII by either user submission or electronic means.

healthcare jobs biotech research clinical trial logistics jobs in memphis fashion employment corporate governance quotient clinical research trial biopharma clinical research software biotech news biotechnology industry news clinical trials data pharmaceutical validation medical device register biotechnology news corporate governance blog pharmaceutical market corporate governance consulting corporate governance training generic pharmaceutical global medical tourism jobs gene pressler clinical diagnostics clinical pharmacology medical devices market medical device pr clinical research consulting gene pitney medical product development bookkeeping jobs nursing jobs medical device sales securities attorney pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter attorney jobs attorney jobs in texas medical device contract manufacturing investment shares corporate governance calpers corporate governance gene tierney pharma manufacturing pharmaceutical clinical research corporate governance practices identity audit pfizer pharmaceutical company

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.